Canopy Growth Receives $0 Price Target from Analyst


Canopy Growth Receives $0 Price Target from Analyst

Canopy Growth's Financial Crisis: Analysts Assign $0 Price Target

New Level Of Relaxation: WholeHemp’s Cherry Blossom CBD
Ontario is dropping its weed profit margins to get the ‘upper hand’ over the illegal market
Are You A Quebecer? Your Right To Homegrown Cannabis Denied

Cannabis producer Canopy Growth, one of the leading players in the Canadian market, recently faced a significant blow as it received a $0 price target from Eight Capital, a prominent financial firm based in Toronto. In a research report titled “Last Puffs of the Roach,” analyst Ty Collin expressed Eight Capital’s view that valuing Canopy as a going concern is no longer appropriate. The report cited several key factors leading to this evaluation.

Canopy Growth’s financial situation

The analysis by Eight Capital highlighted several concerns about Canopy Growth’s financial situation. First and foremost, the company has fewer than 12 months of cash runway, indicating a limited ability to sustain its operations without securing additional funds. This raises questions about the company’s ability to meet its financial obligations and continue its growth trajectory. Furthermore, Canopy Growth faces a lack of viable financing alternatives, which further exacerbates its financial challenges.

Another significant factor contributing to the $0 price target is the large ongoing losses experienced by Canopy Growth, without a clear path to profitability. Despite longstanding efforts to streamline costs, the company has failed to slow down its rate of cash consumption in fiscal year 2023. This has raised concerns about the effectiveness of management’s cost-cutting measures and their ability to turn the company’s financial situation around.

Asset-based/breakup valuation

In light of Canopy Growth’s financial struggles, Eight Capital employed an asset-based/breakup valuation approach to assess the company’s value. According to their analysis, after accounting for Canopy’s substantial debts, the net asset value amounts to zero. This valuation method takes into consideration the company’s assets and liabilities, indicating that the debts outweigh the assets. It underscores the financial challenges faced by Canopy and the significant risks associated with its current operations.

Fragile state of the Canadian cannabis industry

The valuation of Canopy Growth reflects a broader trend within the Canadian cannabis industry. Recent events, such as the bankruptcy of leading cannabis retailer Fire & Flower and the distressed sale of Hexo to Tilray, serve as a reminder that no Canadian cannabis company is immune to failure in the current environment. This highlights the volatile nature of the industry and the need for investors to exercise caution.

Canopy’s recent financial performance

Canopy Growth’s financial performance has been a cause for concern. In June, the company reported a staggering net loss of 3.3 billion Canadian dollars for its fiscal year ended March 31. Such significant losses, coupled with the company’s warning about its ability to continue as a “going concern,” have raised doubts about its long-term sustainability. Furthermore, Canopy’s cash burn rate remains high, with a cash consumption of CA$143 million in its most recent quarter. Despite efforts to streamline costs, the company has struggled to curtail its cash outflow in fiscal year 2023.

Depletion of Canopy’s financial resources

Based on Eight Capital’s analysis, Canopy Growth could potentially deplete its financial resources within the next year. Unless drastic interventions are undertaken and cash costs are significantly reduced, which Eight Capital deems improbable given Canopy’s track record, the company’s coffers could run dry. This adds to the urgency of addressing the financial challenges and finding sustainable solutions to ensure Canopy’s viability in the long term.

Recent developments and actions by Canopy

Canopy Growth has taken some actions in an attempt to address its financial situation. The company recently announced the completion of all conversions related to the $100 million senior unsecured convertible debentures sold to an institutional investor in February 2023. Additionally, Canopy has implemented various balance sheet actions and a business-transformation plan to strengthen its financial position. One such action includes the sale of its facility in Modesto, California, which took place on June 29. Overall, Canopy aims to generate a total of CA$150 million from facility sales by September 30, 2023.

Credit rating and stock exchange listings

In October 2022, Fitch downgraded Canopy’s rating to CCC-, indicating substantial credit risk and a very low margin for safety. This downgrade raises concerns about Canopy’s financial stability and the increased likelihood of default. It further emphasizes the challenges faced by the company in the current market environment. Canopy’s shares trade as WEED on the Toronto Stock Exchange and CGC on the Nasdaq.


Canopy Growth’s $0 price target from Eight Capital underscores the significant financial challenges the company faces. With fewer than 12 months of cash runway, a lack of viable financing alternatives, and ongoing losses without a clear path to profitability, the road ahead is uncertain for Canopy. The fragile state of the Canadian cannabis industry and recent industry failures highlight the need for caution. Canopy’s recent financial performance, high cash burn rate, and potential depletion of financial resources within the next year further exacerbate the concerns.In response to these challenges, Canopy Growth has taken steps to strengthen its financial position, including completing conversions related to convertible debentures and implementing a business-transformation plan. However, the effectiveness of these measures remains to be seen.

In conclusion, Canopy Growth’s $0 price target serves as a wake-up call for the company and the Canadian cannabis industry as a whole. The financial difficulties faced by Canopy reflect the volatile nature of the industry and the need for sustainable business models. The road ahead for Canopy is challenging, requiring decisive actions and strategic planning to navigate through the uncertain landscape.


FAQ 1: What does it mean for a company to receive a $0 price target?

Receiving a $0 price target means that the analyst or financial firm believes the company has no intrinsic value. It indicates that the company’s assets and potential future earnings are insufficient to justify any value for its stock.

FAQ 2: Can Canopy Growth recover from its financial challenges?

Recovering from its financial challenges will be a significant undertaking for Canopy Growth. The company needs to address its cash burn rate, find viable financing alternatives, streamline costs, and demonstrate a clear path to profitability. Successful implementation of these measures, combined with a favorable market environment, could potentially help Canopy recover.

FAQ 3: How has the Canadian cannabis industry been performing overall?

The Canadian cannabis industry has experienced its share of challenges and setbacks. While it initially showed promise after the legalization of recreational cannabis in 2018, the industry has faced regulatory hurdles, oversupply issues, and difficulties in achieving profitability. The bankruptcy of leading cannabis retailer Fire & Flower and distressed sales of other companies highlight the fragile state of the industry.

FAQ 4: Are there any other major cannabis producers facing financial difficulties?

Canopy Growth is not the only major cannabis producer facing financial difficulties. Several other companies in the Canadian cannabis industry have struggled with profitability, high cash burn rates, and challenges related to financing. The overall industry landscape remains challenging for many players.

FAQ 5: How might this affect the stock market and investors?

The $0 price target for Canopy Growth can have a significant impact on the stock market and investors. It can lead to a decline in the company’s stock price and erode investor confidence. Additionally, it may prompt investors to reassess their investments in other cannabis companies, considering the industry’s challenges and the potential for financial instability.